At least 36 individuals lost their lives and approximately three dozen sustained serious injuries, as reported by officials on Tuesday, following a significant explosion at a pharmaceutical factory that ignited a fire in the southern Indian state of Telangana. The day after the explosion, which took place on Monday, firefighters had extinguished the flames and were meticulously searching through the charred remains of the facility located in an industrial park roughly 30 miles from the state capital, Hyderabad, according to G.V. Narayana Rao, the director of the state’s fire services. Emergency personnel surveyed a landscape of twisted metal and scorched concrete while excavators navigated through towering heaps of wires, pipes, and other debris. Many of the injured individuals were admitted to hospitals with burns or were suffering from smoke inhalation; however, Mr. Rao indicated that the death toll was not anticipated to increase. India holds the title of the world’s largest producer of generic pharmaceuticals, and industrial mishaps at drug manufacturing sites are frequent. Nevertheless, Mr. Rao noted that the death toll from the incident on Monday represents the highest number of fatalities from a fire in the state in over 25 years. The facility, located in Sangareddy, is owned by Sigachi Industries and was engaged in the production of microcrystalline cellulose, a material utilized in the creation of medical capsules. While the exact cause of the fire remains uncertain, Mr. Rao mentioned that initial indications suggested a pressure buildup in a dryer system that could have led to a “dust explosion.” In a post on social media, Prime Minister Narendra Modi expressed his sorrow over the loss of lives and committed 200,000 rupees, approximately $2,335, from his National Relief Fund to each of the families of the deceased victims.
